The FDA just voted to approve a different Covid vaccine; this one based on one of the Omicron subvariants. But the decision was anything but simple. A look at the science. Somehow we pulled it off.

Like a Hollywood franchise that churns out sequel after mind-numbing sequel, Omicron is back. Mere weeks after the variant’s BA.2 lineage caused surges globally, two more Omicron spin-offs are on the ...

FRANKFURT (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron ...

When the omicron variant first emerged last November, many doctors, researchers and scientists hoped that the new strain — while more transmissible — would cause fewer deaths. Indeed, early research ...